Eton Pharmaceuticals Inc (ETON)
10.02
-0.44
(-4.21%)
USD |
NASDAQ |
Nov 15, 16:00
9.97
-0.05
(-0.50%)
After-Hours: 20:00
Eton Pharmaceuticals Free Cash Flow (Quarterly): 1.255M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 1.255M |
March 31, 2024 | -4.355M |
December 31, 2023 | 0.387M |
September 30, 2023 | 0.873M |
June 30, 2023 | 7.103M |
March 31, 2023 | -1.548M |
December 31, 2022 | 2.828M |
September 30, 2022 | -3.703M |
June 30, 2022 | 1.70M |
March 31, 2022 | 1.208M |
December 31, 2021 | -8.371M |
September 30, 2021 | -2.952M |
June 30, 2021 | -0.372M |
Date | Value |
---|---|
March 31, 2021 | 3.715M |
December 31, 2020 | -7.226M |
September 30, 2020 | -5.096M |
June 30, 2020 | -2.853M |
March 31, 2020 | -7.221M |
December 31, 2019 | -4.632M |
September 30, 2019 | -3.247M |
June 30, 2019 | -4.838M |
March 31, 2019 | -7.155M |
December 31, 2018 | -1.828M |
September 30, 2018 | -2.343M |
June 30, 2018 | -2.269M |
March 31, 2018 | -1.941M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.371M
Minimum
Dec 2021
7.103M
Maximum
Jun 2023
-1.54M
Average
-1.548M
Median
Mar 2023
Free Cash Flow (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 200.30M |
Integra Lifesciences Holdings Corp | -7.161M |
Elutia Inc | -4.33M |
Immuneering Corp | -11.56M |
Journey Medical Corp | -5.176M |